Calidi BiotherapeuticsCLDI
13F holders, Q2 2026 (June 30)23holders −5
4new positions
9sold out
$0.17avg. 13F price*
At the end of Q2 2026, 23 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, down 5 from Q1 2026. 4 opened new positions and 9 sold out. The largest holders were Geode Capital Management, LLC ($19K), HighTower Advisors, LLC ($14K) and Jane Street Group, LLC ($9K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $16K |
| Exits | 9 | $396K |
All 13F filers, Q1 2026 → Q2 2026: 178,029 shares bought and 1,660,363 shares sold, net −1,482,334 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Geode Capital Management, LLC | 0.00% | Add +81.8% | 114,550 | $19K |
| HighTower Advisors, LLC | 0.00% | No change | 83,523 | $14K |
| Jane Street Group, LLC | 0.00% | Add +56.0% | 54,274 | $9K |
| Independent Advisor Alliance | 0.00% | New | 45,000 | $8K |
| RS Crum Inc. | 0.00% | Add +7.4% | 43,239 | $7K |
| Arax Advisory Partners | 0.00% | No change | 37,345 | $6K |
| Private Advisor Group, LLC | 0.00% | New | 30,000 | $5K |
| Vanguard Capital Management LLC | 0.00% | No change | 25,509 | $4K |
| Belpointe Asset Management LLC | 0.00% | No change | 19,921 | $3K |
| Northern Trust Corp. | 0.00% | No change | 17,758 | $3K |
| Morgan Stanley | 0.00% | Add +39.9% | 13,244 | $2K |
| RFG Advisory, LLC | 0.00% | New | 12,000 | $2K |
| Farther Finance Advisors, LLC | 0.00% | No change | 10,000 | $2K |
| UBS Group AG | 0.00% | New | 7,882 | $1K |
| Citigroup Inc. | 0.00% | Add +32714.3% | 4,594 | $781 |
| Osaic Holdings, Inc. | 0.00% | Add +25.8% | 2,650 | $450 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 1,396 | $237 |
| Highbridge Capital Management LLC | 0.00% | No change | 1,042 | $177 |
| Finepoint Capital LP | 0.00% | No change | 1,042 | $177 |
| SBI Securities Co., Ltd. | 0.00% | Add +226.1% | 375 | $64 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 101 | $18 |
| Reyes Financial Architecture, Inc. | 0.00% | No change | 100 | $17 |
| Evermay Wealth Management LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.